UPMC Hillman Cancer Center

Research Funding Opportunities

UPMC Hillman Cancer Center Developmental Funding Program

Proposal Due Dates: 5:00 PM November 1, 2018 and May 1, 2019

Program Overview

The UPMC Hillman Cancer Center Developmental Funding Program is intended to support the development of cancer research led by Hillman members and to stimulate new applications for extramural funding. All UPMC Hillman Cancer Center members are encouraged to apply.

  • This program funds three categories of awards:
    • Category 1: Pilot Awards
    • Category 2: Collaborative Research Awards
    • Category 3: Team Science Awards
  • Within each category, proposals will be accepted in the following science tracks:
    • Basic Science
    • Clinical/Translational Science
    • Population Science
  • In addition to the main RFAs for each category, targeted RFAs may be added to each funding cycle. Proposals of high merit submitted in any of the three categories listed above may be considered for the targeted RFA mechanism. Please note that proposals do not have to be in the targeted research area.
  • Study sections consisting of Hillman members and chaired by Hillman Associate Directors will review all categories of proposals.
  • Awards have an expected start date of January 1 or July 1, 2019, depending on the funding cycle.
  • Applicants must be UPMC Hillman Cancer Center members.
  • Categories and Targeted Awards

    Category 1: Pilot Awards foster highly innovative, cancer-relevant research. The award will be up to $50,000 for one-year, and only one principal investigator (PI) is allowed per award. See below for details.

    Category 2: Collaborative Research Awards allow for two or more PIs to foster inter- and intra-programmatic collaborations. The award will consist of up to $100,000 per year, for one or two years. Research proposed should be multi-disciplinary, innovative and have potential for advances that can enhance our scientific understanding of cancer and/or clinical and public health practice. See below for details.

    Category 3: Team Science Awards support multi-investigator, team-based efforts to generate data for the development of a program/center grant submission (i.e. P01, SPORE, etc.). The award will consist of up to $100,000 per year, for one or two years. See below for details.

    Targeted Awards are designed to foster research that can meet specific strategic needs, as determined by Hillman's Senior Leadership.

    • Targeted research proposals can be submitted in any of the above categories but will be reviewed by a separate study section.
    • The targeted area of research for this funding cycle is Cancer Health Disparities. See below for details.

    Note: Applicants are allowed to resubmit once. If your proposal is not funded, you may submit the same idea again one time. This limitation is in the interest of stimulating innovation and limiting the burden on reviewers.

    How to Apply

    Applications for this round are due by 5 pm EST on November 1, 2018

    To be eligible for review, applicants must adhere to the following:

    1. Submit Online:
      1. All applicants must register and submit their proposals through the online form on this site. The online form must be completed in one session ‐ it does not save partially entered information and you cannot return to it at a later date to finish your submission.
      2. Registration and submission must be completed by 5:00 pm on the deadline date.
      3. Investigators must submit (upload) their entire application as a single PDF.
        1. The file name must include the PI's last name.
        2. The file size of the single PDF must not exceed 3MB.
    2. Applications missing one or more of the required components (registration and uploaded single PDF with the PI's name in the file name) will be considered incomplete and will not be reviewed.
    3. Extensions of the deadline will not be granted. Supplementary or additional materials will not be accepted after the submission deadline.

      Questions? Email Moira Hitchens, PhD: hitchensm2@upmc.edu

      Category 1 Information

      Application Deadline: 5 p.m. ET, November 1, 2018

      The Category 1 Award is intended to serve as a stimulus for new research initiatives aimed at obtaining sufficient preliminary data to support successful new applications for extramural funding.

      TERMS OF THE AWARDS

      Each award will be up to $50,000 for one year, with an expected start date of January 1. Funds should be expended within one year of receipt. Contact the designated program director for requests to change the start date or extend the funding period (no-cost extension). A report summarizing financial expenditures and a one-page summary of the scientific outcomes of the project will be required two months after the end of funding or earlier if warranted. When requested, all awardees will be expected to provide updates of publications and long-term grant support that originated from the award.

      ELIGIBILITY

      All UPMC Hillman Cancer Center members are eligible and encouraged to apply.

      Category 1 Awards should have only one PI. Applicants can be PI on only one Pilot Award proposal per round. Applicants can be named on other proposals (in the categories with multiple investigators).

      Faculty awardees may be asked to participate in the review process for four future rounds (two years).

      CRITERIA

      Proposals will be judged by the following criteria:

      • Scientific merit and innovation
      • Cancer relevance
      • Qualifications, experience, and productivity of the applicant
      • Project feasibility given facilities, budget, time, and other resources available
      • Potential for future external funding and publications.

      REVIEW

      Proposal review committees will be chaired by a Hillman Associate Director and be composed of UPMC Hillman Cancer Center members, including representation from each research program. The review committees will be made up of both former awardees and ad hoc experts, chosen based on the applications received. Applications will be assigned to at least two reviewers (usually three), who will score applications according to the criteria listed above, using the NIH scale of 1⁃9 (best - worst). A brief summary statement will be provided.

      RESTRICTIONS

      Projects must be completed in the designated period of the grant proposal. Category 1 grants are for one year. Clinical applicants or others with time-consuming protocol requirements may apply for a change in start/end dates. No-cost extensions must be formally requested.

      Funds may be requested for any of the standard NIH budget categories and for purposes deemed necessary for the successful execution of the proposed project. However, restrictions and additional scrutiny apply:

      1. Faculty salary: Requests for salary support of tenure-track or fixed-term faculty as PI or co-investigator are not allowed. Requests for non-tenure track faculty who direct labs or projects, and requests for consulting biostatistics faculty support (for data analysis) can be considered; however, requests for this kind of support should be appropriate for the level of effort required. Salary, tuition, and other funds for non-faculty named on the budget are allowed in amounts appropriate for the level of effort.
      2. Travel: Requests for travel support should be limited to funds directly related to project performance. Such travel, including international, to conferences and meetings is permitted.
      3. Equipment: Requests for equipment should be limited to funds directly related to project performance. For example, a laptop for a research assistant to use in clinic to collect data would be appropriate.

      Unused funds will revert to the supporting funding source. All proposed expenses must conform to the general policies of UPMC Hillman Cancer Center. Projects that use Hillman's Biostatistics Facility, Tissue and Research Pathology Services (TARPS), and/or other shared resources, are encouraged to consult with the facilities prior to submission and include a letter of support from the facility Director.

      REQUIREMENTS FOR AWARDEES

      1. Prior to funding, all awarded projects that involve animals or human subjects must be reviewed and approved in accordance with Hillman's general assurances and HIPAA. Reviews and approvals may be "Just in Time" and are not required for registration/application. Projects involving human subjects must be submitted to an Institutional Review Board (IRB). All investigators and all persons named on the budget page must have certification of training in the protection of human subjects. Appropriate animal forms must also be filed and approved.
      2. A summary progress report must be submitted within two months after the end date of support or earlier if warranted. The summary progress report should give a financial accounting of funds used for the project, and reference all research products planned or generated, including abstracts submitted/published, peer-reviewed articles submitted/published, grant applications submitted/funded, and potential/actual intellectual property (reports of invention, etc.).

        PIs will provide updates on publications, grants, and patents after the end of funding when asked.

        Where applicable, progress reports should identify the Hillman catchment area counties and any minority or medically underserved populations that are involved or affected.

      3. All manuscripts, abstracts, posters, and presentations should acknowledge support from UPMC Hillman Cancer Center Developmental Funds, e.g., This project was supported in part by award number P30CA047904 from the National Cancer Institute. If a Hillman CCSG-supported Shared Resource provided data, please also include the following statement: "This project used the Hillman [insert name(s) of shared resource(s)] that [is/are] supported in part by award P30CA047904." Funded investigators that fail to adhere to this policy will be barred from future submissions to the the Developmental Funding Program for a period of one year.
      4. Awards co-funded by multiple sources will also adhere to reporting and other requirements established by those sources.
      5. Faculty awardees may be asked to serve on review committees.

      APPLICATION FORMAT (in this order)

      All proposals must be submitted as a single PDF and include the following components in the order indicated:

      1. A Title Page that includes:
        1. the title of the proposal;
        2. the PI's name, primary appointment, faculty rank, and contact information;
        3. the funding category (Pilot, Collaborative Research or Team Science) and science track (basic, clinical/translational or population science); and,
        4. the total budget requested.
        5. Note: If applying for the targeted RFA, see the RFA for additional information that should be included on the title page.

        Please note that submitting online does not automatically create this title page.

      2. Scientific Abstract: The abstract summary of the proposal for use by review committee members and UPMC Hillman Cancer Center (250-word maximum).
      3. Budget: Use PHS 398 Form Page 4 https://grants.nih.gov/grants/funding/phs398/398_fp4.docx.
      4. Budget Justification: The Budget Justification should include sufficient detail for reviewers to assess whether appropriate resources have been requested (no page limit).
      5. Research Plan: The Research Plan should follow the standard NIH format: Specific Aims, Significance (including cancer relevance), Innovation, and Approach. Other requirements:
        • Three-page limit, including tables and figures
        • References do not count towards the three-page limit
        • Letters of support do not count towards the three-page limit
        • Single spacing, font no smaller than Arial 11, and half-inch margins
        • All of the above must be included in the single PDF proposal.
        • Note: If applying for the targeted RFA, see the RFA for additional information that should be included in the Research Plan.
      6. Proposal Timeline
      7. Human and/or Animal Subjects: Although Institutional Review Board (IRB) or Institutional Animal Care and Use Committee (IACUC) approval is not required prior to submission, briefly describe any human and/or animal subject issues (no page limit):
        • If human subjects will be involved in the research, provide a description of their involvement and characteristics, specific risks to subjects who participate, and protection against those risks. Describe the sources of materials that will be obtained from human subjects as part of their study participation. Provide assurance that the project will be reviewed and approved by the Hillman IRB and comply with HIPAA.
        • If vertebrate animals are to be used, describe the proposed use of the animals in the work outlined and procedures for ensuring that discomfort, distress, pain and injury will be limited. Projects involving animal subjects must be reviewed and approved by IACUC.
      8. NIH Biosketches for the key members of the research team.

      SUBMISSION

      See submission guidelines on page 1 of this document.

      Questions? Email Moira Hitchens, PhD: hitchensm2@upmc.edu.

      Category 2 Information

      Application Deadline: 5 p.m. ET, November 1, 2018

      The Category 2 Award is intended to support innovative intra- and inter-programmatic research initiatives aimed at obtaining sufficient data to allow new applications for extramural funding.

      TERMS OF THE AWARDS

      Each award must have at least two co-Principal Investigators (co-PIs). The award will consist of up to $100,000 per year, for one or two years, with an expected start date of January 1. A report summarizing financial expenditures and a one-page summary of the scientific outcomes of the project will be required two months after the end of funding or earlier if warranted. When requested, all awardees will be expected to provide updates of publications and long-term grant support that originated from the award.

      ELIGIBILITY

      All UPMC Hillman Cancer Center members are eligible to apply. Category 2 Awards must have two or more co-PIs, and one of them must be chosen as the contact PI. An applicant can be PI on one proposal in this category but a co-investigator on one or more additional proposals per round.

      CRITERIA

      Proposals will be judged by the following criteria:

      • Scientific merit and innovation
      • Cancer relevance
      • Qualifications, experience, and productivity of the co-PIs as well as the potential synergy of their collaboration
      • Project feasibility given facilities, budget, time, and other resources available
      • Potential for future external funding and publications.

      REVIEW

      Proposal review committees will be chaired by a Hillman Associate Director and be composed of UPMC Hillman Cancer Center members, including representation from each research program. The review committees will be made up of both former awardees and ad hoc experts, chosen based on the applications received. Applications will be assigned to at least two reviewers (usually three), who will score applications according to the criteria listed above, using the NIH scale of 1‐9 (best ‐ worst). A brief summary statement will be provided.

      RESTRICTIONS

      Projects must be completed in the designated period of the grant proposal. Category 2 grants are for one to two years, except when otherwise specified in the application and approved by the committee. No-cost extensions will be rare and must be applied for through the designated program director.

      Funds may be budgeted for any of the standard tracks and for purposes deemed necessary for the successful execution of the proposed project. However, restrictions and additional scrutiny apply:

      1. Faculty salary: Requests for salary support of tenure-track or fixed-term faculty as PIs or co-Is are not allowed. Requests for non-tenure track faculty who direct labs or projects and requests for consulting biostatistics faculty support (for data analysis) can be considered; however, requests for this kind of support should be appropriate for the level of effort required. Salary, tuition, and other funds for non-faculty named on the budget are allowed in amounts appropriate for the level of effort.
      2. Travel: Requests for travel support should be limited to funds directly related to project performance. Such travel, including international, to conferences and meetings is permitted.
      3. Equipment: Requests for equipment should be limited to funds directly related to project performance. For example, a laptop for a research assistant to use in clinic to collect data would be appropriate.

      Unused funds will revert to the supporting funding source. All proposed expenses must conform to the general policies of UPMC Hillman Cancer Center. Projects that use Hillman's Biostatistics Facility, Tissue and Research Pathology Services (TARPS), and/or other core resources, are encouraged to consult with those cores prior to submission and include a letter of support from the facility Director.

      REQUIREMENTS FOR AWARDEES

      1. Prior to funding, all awarded projects that involve animals or human subjects must be reviewed and approved in accordance with Hillman's general assurances and HIPAA. Reviews and approvals may be "Just in Time" and are not required for registration/application. Projects involving human subjects must be submitted to an Institutional Review Board (IRB). All investigators and all persons named on the budget page must have certification of training in the protection of human subjects. Appropriate animal forms must also be filed and approved.
      2. A summary progress report must be submitted within two months after the end date of support or earlier if warranted. The summary progress report should give a financial accounting of funds used for the project, and reference all research products planned or generated, including abstracts submitted/published, peer-reviewed articles submitted/published, grant applications submitted/funded, and potential/actual intellectual property (reports of invention, etc.).

        Principal investigators will provide updates on publications, grants, and patents after the end of funding when asked.

        Where appropriate, progress reports should identify the counties and populations involved or affected.

      3. All manuscripts, abstracts, posters, and presentations should acknowledge support from UPMC Hillman Cancer Center Developmental Funds, e.g., This project was supported in part by award number P30CA047904 from the National Cancer Institute. If a Hillman CCSG-supported Shared Resource provided data, please also include the following statement: "This project used the Hillman [insert name(s) of shared resource(s)] that [is/are] supported in part by award P30CA047904." Funded investigators that fail to adhere to this policy will be barred from future submissions to the the Developmental Funding Program for a period of one year.
      4. Awards co-funded by multiple sources will also adhere to reporting and other requirements established by those sources.
      5. Faculty awardees may be asked to serve on review committees.

      APPLICATION FORMAT (in this order)

      All proposals must be submitted as a single PDF and include the following components in the order indicated:

      1. A Title Page that includes:
        1. the title of the proposal;
        2. the contact Co-PI's name, primary appointment, faculty rank, and contact information;
        3. the funding category (Pilot, Collaborative Research or Team Science) and science track (basic, clinical/translational or population science); and,
        4. the total budget requested.
        5. Note: If applying for the targeted RFA, see the RFA for additional information that should be included on the title page.

        Please note that submitting online does not automatically create this title page.

      2. Scientific Abstract: The abstract summary of the proposal for use by review committee members and UPMC Hillman Cancer Center (250-word maximum).
      3. Budget: Use PHS 398 Form Page 4 https://grants.nih.gov/grants/funding/phs398/398_fp4.docx.
      4. Budget Justification: The Budget Justification should include sufficient detail for reviewers to assess whether appropriate resources have been requested (no page limit).
      5. Research Plan: The Research Plan should follow the standard NIH format: Specific Aims, Significance (including cancer relevance), Innovation, and Approach, including a management plan to facilitate collaboration. Other requirements:
        • Three-page limit, including tables and figures
        • References do not count towards the three-page limit
        • Letters of support do not count towards the three-page limit
        • Single spacing, font no smaller than Arial 11, and half-inch margins
        • All of the above must be included in the single PDF proposal.
        • Note: If applying for the targeted RFA, see the RFA for additional information that should be included in the Research Plan.
      6. Proposal Timeline
      7. Human and/or Animal Subjects: Although Institutional Review Board (IRB) or Institutional Animal Care and Use Committee (IACUC) approval is not required prior to submission, briefly describe any human and/or animal subject issues (no page limit):
        • If human subjects will be involved in the research, provide a description of their involvement and characteristics, specific risks to subjects who participate, and protection against those risks. Describe the sources of materials that will be obtained from human subjects as part of their study participation. Provide assurance that the project will be reviewed and approved by the Hillman IRB and comply with HIPAA.
        • If vertebrate animals are to be used, describe the proposed use of the animals in the work outlined and procedures for ensuring that discomfort, distress, pain and injury will be limited. Projects involving animal subjects must be reviewed and approved by IACUC.
      8. NIH Biosketches for the key members of the research team.

      SUBMISSION

      See submission guidelines on page 1 of this document.

      Questions? Email Moira Hitchens, PhD: hitchensm2@upmc.edu.

      Category 3 Information

      Application Deadline: 5 p.m. ET, November 1, 2018

      The Category 3 Award is intended to support efforts of multiple PIs to generate data or purchase a key piece of equipment for the development of a program/center grant submission.

      TERMS OF THE AWARDS

      Each award must have a team of Principal Investigators (co-PIs). The award will consist of up to $100,000 per year, for one or two years, with an expected start date of January 1. A report summarizing financial expenditures and a one-page summary of the scientific outcomes of the project will be required two months after the end of funding or earlier if warranted. When requested, all awardees will be expected to provide updates of publications and long-term grant support that originated from the award.

      ELIGIBILITY

      All UPMC Hillman Cancer Center members are eligible to apply. Category 3 Awards must have a team of co-PIs, and one of them must be chosen as the contact PI. An applicant can be PI on one proposal in this category but a co-investigator on one or more additional proposals per round.

      CRITERIA

      Proposals will be judged by the following criteria:

      • Scientific merit
      • Program integration
      • Cancer relevance
      • Qualifications, experience, and productivity of the co-PIs as well as the potential synergy of their collaboration
      • Project feasibility given facilities, budget, time, and other resources available
      • • Potential for future program/center funding and publications. Preference given to projects targeting the NCI

      REVIEW

      Proposal review committees will be chaired by a Hillman Associate Director and be composed of UPMC Hillman Cancer Center members, including representation from each research program. The review committees will be made up of both former awardees and ad hoc experts, chosen based on the applications received. Applications will be assigned to at least two reviewers (usually three), who will score applications according to the criteria listed above, using the NIH scale of 1⁃9 (best - worst). A brief summary statement will be provided.

      RESTRICTIONS

      Projects must be completed in the designated period of the grant proposal. Category 3 grants are for one to two years, except when otherwise specified in the application and approved by the committee. No-cost extensions will be rare and must be applied for through the designated program director.

      Funds may be budgeted for any of the standard tracks and for purposes deemed necessary for the successful execution of the proposed project. However, restrictions and additional scrutiny apply:

      1. Faculty salary: Requests for salary support of tenure-track or fixed-term faculty as PIs or co-Is are not allowed. Requests for non-tenure track faculty who direct labs or projects and requests for consulting biostatistics faculty support (for data analysis) can be considered; however, requests for this kind of support should be appropriate for the level of effort required. Salary, tuition, and other funds for non-faculty named on the budget are allowed in amounts appropriate for the level of effort.
      2. Travel: Requests for travel support should be limited to funds directly related to project performance. Such travel, including international, to conferences and meetings is permitted.
      3. Equipment: Requests for equipment should be limited to funds directly related to project performance. For example, a laptop for a research assistant to use in clinic to collect data would be appropriate.

      Unused funds will revert to the supporting funding source. All proposed expenses must conform to the general policies of UPMC Hillman Cancer Center. Projects that use Hillman's Biostatistics Facility, Tissue and Research Pathology Services (TARPS), and/or other core resources, are encouraged to consult with those cores prior to submission and include a letter of support from the facility Director.

      REQUIREMENTS FOR AWARDEES

      1. Prior to funding, all awarded projects that involve animals or human subjects must be reviewed and approved in accordance with Hillman's general assurances and HIPAA. Reviews and approvals may be "Just in Time" and are not required for registration/application. Projects involving human subjects must be submitted to an Institutional Review Board (IRB). All investigators and all persons named on the budget page must have certification of training in the protection of human subjects. Appropriate animal forms must also be filed and approved.
      2. A summary progress report must be submitted within two months after the end date of support or earlier if warranted. The summary progress report should give a financial accounting of funds used for the project, and reference all research products planned or generated, including abstracts submitted/published, peer-reviewed articles submitted/published, grant applications submitted/funded, and potential/actual intellectual property (reports of invention, etc.).

        PIs will provide updates on publications, grants, and patents after the end of funding when asked.

        Where appropriate, progress reports should identify the counties and populations involved or affected.

      3. All manuscripts, abstracts, posters, and presentations should acknowledge support from UPMC Hillman Cancer Center Developmental Funds, e.g., This project was supported in part by award number P30CA047904 from the National Cancer Institute. If a Hillman CCSG-supported Shared Resource provided data, please also include the following statement: "This project used the Hillman [insert name(s) of shared resource(s)] that [is/are] supported in part by award P30CA047904." Funded investigators that fail to adhere to this policy will be barred from future submissions to the the Developmental Funding Program for a period of one year.
      4. Awards co-funded by multiple sources will also adhere to reporting and other requirements established by those sources.
      5. Faculty awardees may be asked to serve on review committees.
      6. A program/center grant submission must be made within 24 months of receipt of a Team Science Award. During this 24-month period, the team must submit quarterly updates on the status of their application. For the grant submission, Hillman should receive 51% or more of the indirect costs. If this is not the case, then cost matching with the external department/institution will be required.

      APPLICATION FORMAT (in this order)

      All proposals must be submitted as a single PDF and include the following components in the order indicated:

      1. A Title Page that includes:
        1. the title of the proposal;
        2. the contact Co-PI's name, primary appointment, faculty rank, and contact information;
        3. the funding category (Pilot, Collaborative Research or Team Science) and science track (basic, clinical/translational or population science); and,
        4. the total budget requested.
        5. Note: If applying for the targeted RFA, see the RFA for additional information that should be included on the title page.

        Please note that submitting online does not automatically create this title page.

      2. Scientific Abstract: The abstract summary of the proposal for use by review committee members and UPMC Hillman Cancer Center (250-word maximum).
      3. Budget: Use PHS 398 Form Page 4 https://grants.nih.gov/grants/funding/phs398/398_fp4.docx.
      4. Budget Justification: The Budget Justification should include sufficient detail for reviewers to assess whether appropriate resources have been requested (no page limit).
      5. Research Plan: The Research Plan should follow the standard NIH format: Specific Aims, Significance (including cancer relevance), Innovation, and Approach, including a management plan to facilitate collaboration and a brief overview of the intended program/center grant. Other requirements:
        • Three-page limit, including tables and figures
        • References do not count towards the three-page limit
        • Letters of support do not count towards the three-page limit
        • Single spacing, font no smaller than Arial 11, and half-inch margins
        • All of the above must be included in the single PDF proposal.
        • Note: If applying for the targeted RFA, see the RFA for additional information that should be included in the Research Plan.
      6. Proposal Timeline
      7. Human and/or Animal Subjects: Although Institutional Review Board (IRB) or Institutional Animal Care and Use Committee (IACUC) approval is not required prior to submission, briefly describe any human and/or animal subject issues (no page limit):
        • If human subjects will be involved in the research, provide a description of their involvement and characteristics, specific risks to subjects who participate, and protection against those risks. Describe the sources of materials that will be obtained from human subjects as part of their study participation. Provide assurance that the project will be reviewed and approved by the Hillman IRB and comply with HIPAA.
        • If vertebrate animals are to be used, describe the proposed use of the animals in the work outlined and procedures for ensuring that discomfort, distress, pain and injury will be limited. Projects involving animal subjects must be reviewed and approved by IACUC.
      8. NIH Biosketches for the key members of the research team.

      SUBMISSION

      See submission guidelines on page 1 of this document. The URL for uploading applications will be made available at least two weeks prior to the submission deadline.

      Questions? Email Moira Hitchens, PhD: hitchensm2@upmc.edu.

      Targeted RFA Information

      The Hillman Developmental Funding Program seeks to encourage new research that addresses cancer health disparities in the UPMC Hillman Cancer Center catchment area. Population groups disproportionately affected by cancer include race/ethnicity minorities (African American or Black, Asian, American Indian or Alaska Native, Native Hawaiian or other Pacific Islander, and Latino or Hispanic); sexual and gender minorities; and, individuals with disabilities, low socioeconomic status, rural residence or other attributes associated with being socially disadvantaged. Many of these sub-populations reside within Hillman's 29-county catchment area. For example, the majority of Hillman’s catchment area consists of rural counties (Figure 1) with low socio-economic status. Not surprisingly, most of the 29 counties have higher cancer incidence and mortality rates than the national average (see EDDIE and State Cancer Profiles for PA-related cancer data). The overarching goal of this funding opportunity is to initiate research addressing the specific and unique socioeconomic, environmental, biologic, and behavioral factors that contribute to cancer health disparities within our catchment area as a way to reduce cancer burden in western PA.

      Proposals focused on cancer health disparities can be submitted in response to the solicitation for all three categories of awards: Pilot, Collaborative Research, and Team Science. To apply for this targeted award, follow the guidelines listed in each category with the following additions:

      1. State on the title page that the project addresses cancer health disparities.
      2. Include in the research plan the specific Hillman catchment area counties and any minority or medically underserved populations involved in the study.

      The criteria remain the same as what is described in the guidelines; however, proposals will also be scored on their relevance to the Hillman catchment area.

      Questions? Please contact Moira Hitchens, PhD (hitchensm2@upmc.edu) or Linda Robertson, RN, MSN, DrPH (robertsonlk@upmc.edu) with any questions regarding development funding for cancer health disparities.